Menu

NEW YORK (GenomeWeb) – In a move that surprised legal experts, a South Carolina federal district court has denied Quest Diagnostics' motion to dismiss several allegations it is facing in a wrongful death lawsuit, allowing the case to move to discovery.

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect.